2-Hydroxy-4-methoxybenzaldehyde
Common Name: |
2-Hydroxy-4-methoxybenzaldehyde |
IUPAC Name: |
2-hydroxy-4-methoxybenzaldehyde |
Molecular Formula: |
C8H8O3 |
SMILES: |
COC1=CC(=C(C=C1)C=O)O |
Inchi: |
1S/C8H8O3/c1-11-7-3-2-6(5-9)8(10)4-7/h2-5,10H,1H3 |
Inchi Key: |
WZUODJNEIXSNEU-UHFFFAOYSA-N |
Cas No: |
673-22-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
152.15 |
Mass (g/mol) |
152.047 |
Molar Refractivity |
40.34 |
Net Charge |
|
HBD |
1 |
HBA |
3 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
46.53 |
Hetero Atoms |
3 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
41.00 to 43.00 |
Boiling Point (°C@760.00mm Hg) |
269.00 to 270.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.004 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.12 |
LogP |
1.213 |
iLOGP |
1.40 |
XLOGP3 |
0.87 |
WLOGP |
1.21 |
MLOGP |
0.51 |
ESOL Log S |
-1.60 |
ESOL Solubility (mg/ml) |
3.8 |
ESOL Solubility (mol/l) |
0.025 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.43 |
Ali Solubility (mg/ml) |
5.64 |
Ali Solubility (mol/l) |
0.04 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.88 |
Silicos-IT Solubility (mg/ml) |
2 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.61 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.896 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.507 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |